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Abstract Many studies have been reported in the literature on
the effects of various geometries and lengths of microneedles
(MNs) on transdermal drug delivery using a variety of drug
molecules. In particular, sharp-tipped MNs have been used to
disrupt the top layer of the skin, namely, stratum corneum
(SC). It has also been shown that short- and flat-tipped MNs
can pierce the SC and they have the potential to increase drug
permeability. However, there is little work that explores MNs
as a skin ablative tool with a view to increasing skin perme-
ability. To address this point, well-defined small patterns (size
of individual pattern 10–20 μm) on the tip of flat MN (tip
radius of individual MN ∼250 μm) were created and their
effects evaluated on the permeability of bovine serum albumin
(BSA), which is chosen as a model drug of high molecular
weight. The patterns on the tip of flat MN act as rough sur-
faces (e.g. like sand paper) which when applied on the surface
of the skin ablate the SC layer. Focused ion beam (FIB) has
been used as the fabrication technique for the MNs. The per-
meability data are then compared with the other data for flat-
and sharp-tipped MN. The permeability data from passive
diffusion experiments are used as the reference case. The exact
number of MNs or patterns in the flat and patterned MN
patches is not considered as important as they have not been
designed to pierce the skin. However, this is an important
consideration in the case of sharp MNs as they pierce and
create cavities in the skin. It is found that the delivery of
BSAwith the fabricated flat and patterned MNs gave similar
but somewhat lower drug permeation profile in comparison to
the sharp MNs. Passive diffusion showed no permeation, as
would be expected due to the large size of the chosen
molecule.
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Introduction
Microneedles (MNs) are a transdermal drug delivery system
that combines the technology of transdermal patches and hy-
podermic needles. There are two key types of MNs, namely,
solid and hollow MNs [1, 2]. The materials that have been
used to fabricate the MNs range from metals [3], glass [4],
silicon [5], biodegradable polymers [6, 7] and silk fibroin [8].
Ideally, these materials would be pharmacologically inert,
non-toxic and compatible with pharmaceutical ingredients,
etc. [9]. The metals traditionally used for MN fabrication con-
sist of stainless steel, nickel coated in gold, titanium, platinum
and palladium [10, 11].
MNs have been used to deliver several high molecular
weight drugs. For example, bovine serum albumin (BSA)
has been used as a model drug in several journal papers
[12–14] to characterise the role of various MN geometries
on drug permeation in the skin. MNs perform by disrupting
the skin and thereby increasing drug permeability. MNs are
scarcely less than 150 μm in length, but a study conducted by
Wei-Ze et al. [5] explored the fabrication of super short MNs
with a length of 70–80μm. These authors compared the use of
sharp-tipped super-short MNs against blunt super-short MNs
and longer sharp needles of 1500 μm. Their results concluded
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that both sharp and blunt super-short MNs are capable of
successfully delivering the Alzheimer’s drug galanthamine
[5].
Passive diffusion of molecules can typically occur with
molecules that are less than 500 Da [15]. Therefore, in order
to allow permeation of larger molecules such as BSA (approx-
imately 66.5 kDa), the rate-limiting barrier of the skin, i.e. the
stratum corneum layer, needs to be disrupted in some form.
For this purpose, various skin ablation techniques involving
micro- or nano-derma abrasion have been attempted [16–18].
However, there is little discussion on how these methods com-
pare with MNs. Furthermore, there is little or no work that
explores MNs as a tool for ablating the skin surface.
In addressing these points, this short communication will
note the effect of flat-tipped MN and a well-defined patterned
MN that ablates the skin to compare the permeation of BSA as
a model drug. These permeation data will also be compared to
the data from a sharp-tipped MN. Focused ion beam (FIB) is
used as the manufacturing technique that can facilitate the
fabrication of a well-defined geometry on the tip surface of a
flat MN, which is used to ablate the skin. This is in contrast to
theMNs used in the study byWei-Ze et al. [5], where theMNs
were used to pierce the skin. An attempt will be made to
evaluate if having a rough surface on the tip of the flat MN
tip will have any effect on the drug permeability.
There are multiple technological advances in transdermal
drug delivery research that are currently being undertaken. For
example, various combinational methods where microneedles
have been combined with ultrasound and iontophoresis have
been tried [13, 19]. Another example is the use of laser-
engineered dissolving MN arrays for the delivery of vaccina-
tions [20].
FIB has been used in this work as it is a technique that can
allow a micron-sized shape to be prepared on the tip of the flat
MNwith good accuracy. This is a novel method to ascertain if
applying a pattern on to the tip of a flat MN surface has an
effect on permeability. The exact number of patterns on the tip
of the well-defined patterned MN is not considered as the aim
of this paper is to establish whether a physical ablation tech-
nique has an effect on permeability, compared to physically
piercing skin.
Materials and methods
Materials
BSA and methylene blue were purchased from Sigma-
Aldrich (Gillingham, Dorset, UK). A reverse phase
high-performance liquid chromatography (RP-HPLC) in-
strument (Agilent Series 1100, Cheadle Cheshire, UK)
was used to determine BSA concentration. Two reagents,
acetonitrile and trifluoroacetic acid (TFA), were used as
the mobile phases for the HPLC analyses. They were
obtained from Fisher Scientific UK Ltd (Loughborough,
UK). A Jupiter C4 300A HPLC column (length 150 mm,
internal diameter 4.6 mm) column equipped with a secu-
rity guard column fitted with a Widepore C4 (4×
3.0 mm) cartridge (Phenomenex, Inc., Macclesfield,
UK) was used to quantify the samples containing BSA.
A manual Franz diffusion cell (FDC) (Logan Instruments
Corporation, New Jersey, USA) was used to conduct the
permeation studies with and without MNs. Deionised
water purified using a Millipore Elix System (Billerica,
MA, USA) was used for all FDC experiments. Fresh
porcine full thickness skin was purchased from Welsh
School of Pharmacy, Cardiff University, Cardiff (UK)
in pre-cut 2.5-cm2 sections. The porcine skin samples
were prepared by first removing the porcine ear from
the main body of the animal. The hairs were then care-
fully shaved off the ear using electric clippers to ensure
the surface of the skin was not damaged. The skin was
then removed off the ear cartilage with a scalpel and cut
into 2.5-cm2 sections. Samples were shipped via special
delivery in insulated packaging on the same day of ex-
cision. The skin samples are then stored in the freezer at
−22 °C. Before the permeation experiments, samples
were placed in a beaker of deionised water to thaw for
1 h and then patted dry with laboratory tissue. Commer-
cially available microneedle patch with 1500-μm-long
MN was purchased from AdminPatch (Sunnyvale, CA,
USA) and used to pre-treat the porcine skin. It was
shown by Cheung et al. [21] that the length of this MN
does not completely create a cavity in the skin, which
has the same length as the MN. This is due to the vis-
coelasticity of the skin which causes smaller holes [13].
This patch has been proved to help passage of large
molecules through the skin [13, 21]. This MN patch
has been used in previous work to characterise the
BSA release in FDC experiments and therefore would
be good to relate the flat and FIB fabricated MNs. There
are 31 individual needles on this MN patch, and each is
1400 μm in length. The main characteristics of the MNs
have been reported previously by Cheung et al. and are
not repeated here [21].
BSA release measurements using Franz diffusion cell
A Franz diffusion cell apparatus was used to measure the BSA
permeability in skin [18]. One thousand microgrammes per
millilitre of BSA containing solution was placed into the do-
nor chamber and samples extracted from the receiving com-
partment at time points of 15 min, 30 min and 1, 1.5, 2, 3, 4
and 5 h. The procedures for conducting the permeation exper-
iments are similar to the work conducted byHan and Das [13],
and therefore, they are not discussed in this paper in detail.
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MN insertion into porcine skin
The porcine skin in this study was not stretched when a force
was applied which was conducted in a similar manner to MN
insertion by Cheung et al. [21]. An in-house force device was
used to insert the MN. The method for this is outlined by
Cheung et al. [21]. After an MN array was placed onto the
porcine skin, it was removed and placed onto the receptor
chamber of a diffusion cell. The properties of the purchased
AdminPatch® 1500 MN and skin are also shown in Cheung
et al. [21].
Method of analysing BSA concentration using HPLC
The concentration of the sample from the FDC experiment
was analysed by RP-HPLC. The diode array detector (DAD)
was set at 232 nm. A spectrophotometer (SHIMADZU UV
mini 1240) was used to determine the specific wavelength
when the light absorbance was at the maximum. A gradient
method was adopted with eluent A: 0.1 % TFA in water and
B: 0.08 % TFA in acetonitrile, with a mobile phase ratio of A:
B, 95:05 to 20:80. The sample size of each injection was
10 μL. The temperature was set to 24 °C. The flow rate was
set to 1 ml/min. A complete RP-HPLC run took approximate-
ly 20 min with a down time of 2 min between each run. An
external standard approach was used for the standardisation
for the analysis of the component sample BSA. External stan-
dard samples were prepared using pure chemicals of BSA
purchased from Sigma-Aldrich and dissolved in deionised
water, purified by Millipore Milli-Q Plus 185. Standards of
concentration ranging 10–100 μg/ml BSAwere prepared and
analysed by HPLC to obtain the absorbance.
Preparation of flat and patterned MNs
As mentioned earlier, this note will compare the use of
flat MNs and FIB patterned MNs to create a sand paper-
like texture and bought MNs (AdminPatch® 1500) to
investigate the amount of BSA permeation. Two hundred
fifty-micrometre-diameter, 250-μm-long flat MNs were
fabricated to look at the effects of flat MNs on the con-
centration of bovine serum albumin (BSA) compared to a
long sharp MN.
A stainless steel mounting block (H×L×W: 5 mm×
25 mm×17 mm) with nine 2-mm-diameter drilled holes
(Fig. 1a) was machined to mount 250-μm-diameter
stainless steel wires upright. The steel wires were pur-
chased from Goodfellow Cambridge Limited (Hunting-
don, UK). A translucent Perspex sheet of 1 mm thick-
ness was used to make the MN base unit and cut using
a milling machine. This had a 3×3 array of nine holes
with 0.25 mm diameter drilled with a 1.5-mm spacing
(as shown in Fig. 1b). A stainless steel MN mould with
a 0.25-mm depth well drilled into it allowed the wires
to be mounted at the same height (0.25 mm) (Fig. 1c).
To prepare flat MNs, the stainless steel wires were
thread into the stainless steel block (Fig. 1a). Hot
modelling wax was then placed inside the hole to hold
the wire in place. The top surface of the block was then
ground for approximately 5 min for each grade of sili-
con carbide paper (dampened with water), using coarse
grit sizes, first, 220, 1200 and then 2400, manufactured
by Struers. This was the method to create the flat MN.
This same starting point was used to create the FIB
patterned MN. The patterning was performed in an
FEI Nov. 600 Nova Nanolab dual beam Focused Ion
Beam/Field Emission Gun Scanning Electron Micro-
scope (FIB/FEG-SEM). Simple pattern templates were
produced by designing a grid pattern that contained 52
15 μm×15 μm square patterns in Photoshop and were
input directly into the patterning engine of the dual
beam as a bitmap image. Patterning was performed
using a 30-kV Ga+ beam and a current of 20 nA, and
the cutting progress was monitored using the SEM in
real time.
Flat MNs were assembled by removing the ground wires
from the mounted block and threading them through the 0.25-
mm-diameter holes perspex mounting disc (Fig. 1b) (ensuring
the ground end was not threaded through). Once all the wires
were threaded, the MN disc was then placed onto the PTFE
MN mould with the ground end of the wires pushed gently
into the mould to ensure all the needles were at the same
length (Fig. 1c). The wires were then glued in place with
araldite and left to dry in the mould. A MN holder was then
placed on top to conceal the excess wires (Fig. 1e). This was
also the mounting piece for allowing a specific force to be
applied to porcine skin. Figure 1e depicts the MN mould
and mount with the MN contained inside. The patterned MN
was mounted in a similar manner. The MN would be a nine-
array MN with a pitch of 1.5 mm. The MNs made using FIB
technique were fabricated to ascertain if the flatMNs that were
patterned allowedmore drug to permeate through porcine skin
compared to the flat MNs that were produced.
Characterisation of Microneedles
Surfacemorphology characterisation was conducted using op-
tical microscopy, SEM and infinite focus 3D microscopy
(Graz, Austria). These analysis techniques were used to deter-
mine if the surface of the MN was uniform. A Canon (Surry,
UK) microscope was used to initially visualise if the top sur-
face of the needles were ground flat. SEM images were used
to image pre- and post-ion beam milling of the material. 3D
microscopy images were taken using the instrument Infinite
Focus by Alicona (Kent, UK).
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Results and discussion
Characterisation of MNs
The flat MNs were analysed using microscopy to visualise
their initial profiles in order to ascertain if further grinding
was required. Once the needles were sufficiently flat, they
were then characterised using 3D microscopy to characterise
the flat tip profile, as shown in Fig. 2a–c. Using various grades
of silicon carbide paper was an effective technique to obtain
flatMN structures. It can be seen that there is no burring on the
sides of the needles, even if the method used excessive force
to grind the needles. This is because the modelling wax used
to hold to wired prevented any movement. The 3D microsco-
py images as shown in Fig. 2b, c show further that the silicon
carbide paper produced flat profile MNs.
The patterned MNs were initially produced and
characterised in an identical manner to the flat MNs. These
images are depicted in Fig. 3a–c. The flat MNwas placed into
a FIB chamber for micro-patterning. Figure 3a shows a SEM
image of the flat MN after the micro-patterning with FIB, and
it shows that the edges of the needle are slightly covered by
residual wax. Consequently, the patterned MN was cleaned
prior to any permeation experiments. 3D microscopy images
as shown in Fig. 3b, c were also taken of the patterned MNs in
order to obtain a depth profile of the patternedMN to ascertain
if they were successfully patterned to the specification
outlined. The 3D microscopy results showed that the pattern
and the profile were consistent. Therefore, the SEM images
produced at the time of ablation will be sufficient enough to
visualise the tips of the well-defined FIB needle. The images
of the tip were taken after they were cleaned. In the case of the
microscopy images, it is shown that SEM produced a clearer
image of the FIB structure than using 3D microscopy. How-
ever, the 3D microscopy can give an indication of the height
of the patternedMN tips which was shown to be approximate-
ly 4 μm. Two views of the commercially available sharp
microneedle patch which we have used in this work to pre-
treat the porcine skin are shown in Fig. 3d, e.
Skin permeation of BSA
The concentration of BSA in the receptor chamber was calcu-
lated over a period of 5 h (300 min) from the time when the
donor compound of concentration 1000 μg/ml BSA was
placed into the donor chamber. Full thickness of porcine skin
was used as the membrane. Four parameter experiments were
conducted: passive diffusion (no MN insertion), the use of
well-defined patterns on the tip of flat MN to ablate the skin
(FIBMN), fabricated short flat MN (ablation of the skin to act
like sand paper) and the insertion of a sharp MN. A repeat of
ten experiments was conducted and the average results pre-
sented. The results for the FIB fabricated patterned MNs
showed a similar BSA release profile compared to flat MN,
therefore indicating that the patterned MN showed little to no
difference in drug permeability as that of flat MNs. The MN
Fig. 1 a Stainless steel mounting
block, b microneedle backing
plate, c stainless microneedle
mouldmount, d ground surface of
250 μm stainless steel wire
mounted in stainless steel block
held by modelling wax, eMN
mould and mount with the MN
contained inside and fMN
geometry pitch 1.5 mm
Fig. 2 a Single SEM image and
b, c single 3Dmicroscopy images
of 250 μm stainless steel wires
ground using three grades of
silicon carbide paper to make flat
short MNs
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was placed onto the porcine skin for 3 min using the pneu-
matic pump. Passive diffusion was used as a control.
It was observed (Fig. 4) that the concentration of BSA
increased over time for all MN insertions but produced no
concentration of BSA for passive diffusion. This is because
the molecular size of BSA is too large to passively diffuse
through the SC layer of the porcine skin. Similar results have
been shown in the literature [22]. After 5 h, the concentration
of BSAwhen a sharp MNwas applied to porcine skin showed
an approximate concentration of 120 μg/ml compared to no
insertion of MN on porcine skin. Whereas after 5 h, the con-
centration of BSAwhen a flat MN 250 μm diameter, 250 μm
length, was applied to porcine skin showed an approximate
80μg/ml concentration difference compared to no insertion of
MN on porcine skin. The patterned MN gave a 7-μg/ml less
concentration compared to the flat MN. This shows a small
drug release difference compared to the sharp MN, and
therefore, it is observed that the patterned and flat MN gave
similar drug release profiles.
The results for the insertion of flat and sharpMNs showed a
similar trend with the concentration of BSA being approxi-
mately 40 μg/ml greater for sharp MNs than flat MNs over
5 h. There is a greater diffusion of BSA through the porcine
skin when a MN is inserted into the porcine skin compared to
no MN insertion. This is because the MN created channels in
the skin which allow the passing of a larger concentration of
BSA to diffuse through the full skin thickness. The channels
that have been opened allow a greater diffusion environment
allowing large molecules to permeate through the porcine
skin. Flat MNs show a promising permeability of MN com-
pared to sharp MNs, where by the skin is ablated rather than
directed pierced. Similar results have been shown in the liter-
ature conducted by Wei-Ze et al. [5]. However, they showed
that super-short MNs are capable of successfully delivering
galanthamine (GAL) with a higher permeation than sharp
MNs. From our results, it can be observed that the flat MNs
give lower concentration profiles to the chosen sharp MNs.
However, the concentration difference is not different enough
to suggest that flat MN could not be used as an alternative to
sharp MNs. This would infer that the flat MNs could be used
as an alternative to conventional long sharp MNs and avoid
the problems associated with pain from long MNs [23].
It has been shown in the literature by Han and Das [24] that
the amount of drug release as a result of MN insertion is
largely affected by the length of the MNs themselves. There-
fore, the resultant drug release profile from insertion of the
sharper MN compared to the insertion of flat and well-
defined MNs seems to be consistent with the observations
made by Han and Das [24]. The sharp MN is nearly six times
the length of the other two MNs used. As there is a slight
height difference in the MN length for the flat and well-
defined MNs of approximately 4 μm, the question to ask is
whether this is a significant height variation in MN length to
Fig. 3 a SEM image of a
completed FIB needle and b, c
single 3D microscopy images of
250 μm stainless steel wires
ground using three grades of
silicon carbide paper to make flat
MN prior to micro-patterning
with FIB. c A contoured coloured
image of the FIB microneedle. d
Front view image of the
AdminPatch array (1500 μm
long); e side image of the
AdminPatch Array (1500 μm
long)
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Fig. 4 Concentration of bovine serum albumin (BSA) over a period of
300 min when a solution of BSA concentration 1000 μg/ml is applied
onto full thickness porcine skin in vitro, with no microneedle (passive
diffusion) and insertion of flat microneedle, FIB microneedle and a long
sharp microneedle for a period of 3 min. All experiments have been done
with ten repeats
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deduce a significant difference in drug release profile. As Han
and Das have illustrated the actual MN penetration depth in
the skin is not the same as the length of the MN, we have
assumed that this height difference is negligible in this case.
Conclusion
It was shown that the delivery of BSA with fabricated flat
microneedles (approximate concentration of 80 μg/ml) gave
a similar drug release profile in comparison to well-defined
FIB fabricated patterned MNs (approximate concentration of
70 μg/ml) after 5 h. The sharp MNs showed an increase of
drug release in comparison to the flat MNs, but they are ex-
pected to be more painful when inserted into the skin. Passive
diffusion gave no permeation data, as would be expected due
to the large molecular size of the molecule. The results for the
sand paper like MNs fabricated using FIB showed similar
BSA release as the flat MNs (250 μm diameter, 250 μm
length), therefore indicating that the sand paper MNs showed
negligible difference in drug permeability as that of the flat
MNs. The results show that using FIB as a technique to create
a sandpaper effect to porate the skin is an effective tool.
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